Physician profile
George B Bittar
NPI 1801869615
$8,217.28
in general payments reported to CMS, 2019-2025
20 companies · $864 in 2025
The $864 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,089 · 2020: $966 · 2021: $228 · 2022: $661 · 2023: $435 · 2024: $975 · 2025: $864.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,273.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,273.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $2,805.45 | 2019-2020 | |
| Boston Scientific Corporation | $1,088.43 | 2019-2025 | Watchman Flx |
| Edwards Lifesciences Corporation | $799.64 | 2019-2021 | |
| Abbott Laboratories | $790.24 | 2021-2025 | Mitraclip |
| Medtronic, INC. | $527.18 | 2024-2025 | Ffrangio, Endurant Iis, Onyx Frontier |
| Endologix LLC | $458.91 | 2024 | Endocross Device, Torus Stent Graft System |
| E.R. Squibb & Sons, L.L.C. | $314.44 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $241.99 | 2019-2023 | Farxiga |
| Janssen Pharmaceuticals, INC | $238.98 | 2019-2022 | |
| Novo Nordisk INC | $150.80 | 2024-2025 | Wegovy, Rybelsus, Ozempic |
| Shockwave Medical, INC | $149.90 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Lundbeck LLC | $124.74 | 2019 | |
| Merck Sharp & Dohme LLC | $120.53 | 2023 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $108.66 | 2020-2023 | Jardiance |
| Merit Medical Systems INC | $100.48 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $67.10 | 2019 | |
| Baxter Healthcare | $55.00 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Cook Medical LLC | $34.77 | 2025 | Cook |
| Biotronik INC. | $21.82 | 2025 | Amvia Edge |
| Cvrx, INC. | $18.22 | 2024 | Barostim Neo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Bittar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.